Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

por Thangaraj, Jaya Lakshmi, Jung, Sung-Hoon, Vo, Manh-Cuong, Chu, Tan-Huy, Phan, Minh-Trang Thi, Lee, Kyung-Hwa, Ahn, Seo-Yeon, Kim, Mihee, Song, Ga-Young, Ahn, Jae-Sook, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Cho, Duck, Lee, Je-Jung
Publicado 2022

Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model

por Tran, Thi-Anh-Thuy, Kim, Young-Hee, Duong, Thi-Hoang-Oanh, Thangaraj, JayaLakshmi, Chu, Tan-Huy, Jung, Shin, Kim, In-Young, Moon, Kyung-Sub, Kim, Young-Jin, Lee, Tae-Kyu, Lee, Chul Won, Yun, Hyosuk, Lee, Je-Jung, Lee, Hyun-Ju, Lee, Kyung-Hwa, Jung, Tae-Young
Publicado 2023